Doddivaripalli will drive the next phase of DexCare’s platform, helping more health systems treat up to 40 percent more patients with the resources they already have
DexCare, Inc., today announced that Ravi Doddivaripalli has joined the company as its chief technology officer. Doddivaripalli brings experience scaling SaaS platforms with expertise in AI, real-time data integration, and scalable architecture across healthcare and enterprise environments.
“We can build and deploy at a pace that wasn’t possible a few years ago,” said Matt Blosl, CEO of DexCare. “Our platform already connects data, capacity, and demand across some of the largest health systems in the country. Ravi brings the architectural depth and platform experience to accelerate what we’ve built to help more health systems treat more patients with the resources they already have.”
Doddivaripalli joins DexCare from XY Retail Inc., where he served as chief product and engineering officer, leading platform strategy, AI services, and global engineering operations during a period of rapid growth. Over his 25-year career, he has held senior platform and engineering roles across healthcare and enterprise organizations, including Hewlett-Packard, Innovaccer, Delta Dental of California, Sephora, and Salesforce.com.
“Effective navigation matches patient needs with available capacity at the moment they’re looking for care,” said Ravi Doddivaripalli, chief technology officer at DexCare. “That match depends on data hygiene, interoperability, and routing logic that’s built to execute at an enterprise scale. My focus is to advance our platform, including the real-time data processing and AI models, so DexCare can expand to more health systems, care settings, locations, teams, and the workflows that determine how patients get to care.”
Health systems using DexCare treat up to 40 percent more patients with the same clinical resources and reduce the time to appointment by five days. The DexCare platform ingests, standardizes, and activates data from scheduling systems, EHRs, and patient applications to create a single, transactable foundation that makes patient routing possible at enterprise scale. Under Ravi’s leadership, DexCare will advance its routing intelligence and expand the platform across more health systems, modalities, and care settings.
“Ravi has built platforms on a global scale, and he understands what it takes to displace the systems and processes that have held an industry back,” said Blosl. “Healthcare is facing more demand, fewer providers, and thinner margins. Patient navigation—the intelligence to direct where, when, and how they’re matched to the right care—is no longer a nice-to-have when clinical resources are under such pressure. With Ravi, we’ll make it easier for patients to find care than it is to avoid it.”
DexCare is backed by leading institutional investors such as ICONIQ Growth, Transformation Capital, Define Ventures, Frist Cressey Ventures, and SpringRock Ventures, as well as strategic partners including Providence, Kaiser Permanente, Mass General Brigham, Tampa General, and Texas Health Resources.
About DexCare
DexCare is infrastructure for patient navigation. The platform connects scheduling data across EMRs, workflows, and access points so health systems can route patients to available care, regardless of where they enter or what modality they need. Health systems use DexCare to treat more patients without adding clinical resources. The result: reduced wait times, filled capacity, and growth. With DexCare, health systems route with confidence. It works enterprise-wide, across primary and specialty care, for rural and urban patients alike. DexCare serves more than 57 million patients across 50 states and partners with leading systems including Providence, Kaiser Permanente, El Camino Health, SSM Health, Texas Health Resources, and Piedmont.
